Shilpa Medicare has informed that Shilpa Medicare, headquartered at Raichur, Karnataka, India, has received Marketing Authorization from Germany, EU for Amifampridine Tablets, 10 mg under the National Procedure.
The above information is a part of company’s filings submitted to BSE.